Nicholson, C. David has filed 13 insider transactions across 2 companies since June 2024.
Most recent transaction: a disposition of 8000 shares of Adverum Biotechnologies, Inc. ($ADVM) on December 09, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Nicholson, C. David | Not found | D | Stock Option (Right to Buy) | 8000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.03% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Nicholson, C. David | Not found | D | Stock Option (Right to Buy) | 10450 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.04% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Nicholson, C. David | Not found | D | Stock Option (Right to Buy) | 10520 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.04% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Nicholson, C. David | Not found | A | Stock Option (Right to Buy) | 10450 | $0.00 | 10,450.0000 | 19,782,000 | 9999.99% | 0.05% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Nicholson, C. David | Director | D | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.01% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Nicholson, C. David | Director | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.03% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Nicholson, C. David | Director | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.03% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Nicholson, C. David | Director | D | Stock Option (Right to Buy) | 18351 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.06% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Nicholson, C. David | Director | D | Stock Option (Right to Buy) | 72156 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.24% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Nicholson, C. David | Director | D | Stock Option (Right to Buy) | 70311 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.23% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Nicholson, C. David | Director | D | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.01% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Nicholson, C. David | Director | D | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.01% |
| June 17, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Nicholson, C. David | Not found | A | Stock Option (Right to Buy) | 10520 | $0.00 | 10,520.0000 | 16,479,000 | 9999.99% | 0.06% |